logo

Pfizer Inc. (PFE)



Trade PFE now with
  Date
  Headline
2/11/2019 5:11:28 PM Pfizer, Astellas: Phase 3 ARCHES Trial In Men With MHSPC Met Primary Endpoint
2/1/2019 9:17:50 AM Pfizer Receives Positive CHMP Opinion For Vizimpro 45 Mg
1/29/2019 6:45:45 AM Pfizer Q4 Reported Loss Per Share $0.07; Adj EPS $0.64
1/29/2019 6:30:43 AM Pfizer And Eli Lilly Report Positive Top-line Results From Phase 3 Study Evaluating Tanezumab
1/14/2019 8:01:49 AM Pfizer : FDA Accepts Regulatory Submissions For Review Of Tafamidis To Treat Transthyretin Amyloid Cardiomyopathy
1/7/2019 8:08:50 AM CytoReason Signs Deal With Pfizer To Utilize CytoReason’s Machine Learning Model Of Immune System For Drug Discovery
1/3/2019 8:33:35 AM Pfizer Begins Phase 2b/3 Clinical Trial For Oral JAK3 Inhibitor, PF-06651600